Zobrazeno 1 - 9
of 9
pro vyhledávání: '"John F. Hoke"'
Autor:
Natalie D. Eddington, Zhongming Liang, John F. Hoke, Julian E. Moreton, Sam H. Haidar, Keith T. Muir
Publikováno v:
Journal of Pharmaceutical Sciences. 86:1278-1282
Remifentanil (Ultiva) is a novel, ultra-short-acting opioid which has recently been approved for use as an analgesic during induction and maintenance of general anesthesia. Esmolol is a short-acting beta-blocker used during surgical procedures to red
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6932cd157bed49967c858b8aa62425f4
https://doi.org/10.1021/js970079e
https://doi.org/10.1021/js970079e
Autor:
Valerie Billard, Charles F. Minto, Thomas W. Schnider, Jaap W. Mandema, Talmage D. Egan, David J. Hermann, John F. Hoke, Steven L. Shafer, Pedro L. Gambús, Harry J. M. Lemmens, Katherine H. P. Moore, Keith T. Muir, Elizabeth J. Youngs
Publikováno v:
Anesthesiology. 86:10-23
Background Previous studies have reported conflicting results concerning the influence of age and gender on the pharmacokinetics and pharmacodynamics of fentanyl, alfentanil, and sufentanil. The aim of this study was to determine the influence of age
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b10b85f154bca0381b04a14764242b3
https://doi.org/10.1097/00000542-199701000-00004
https://doi.org/10.1097/00000542-199701000-00004
Publikováno v:
Drug Metabolism Reviews. 23:375-411
As a result of their ability to transport oxygen, PFC emulsions are being investigated for possible use in a wide variety of conditions. The recent FDA approval of F-DA to diminish myocardial ischemia during angioplasty is the first marketing approva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f51ee020e86d2008c806f9e6175b63e9
https://doi.org/10.3109/03602539109029765
https://doi.org/10.3109/03602539109029765
Autor:
Fania Szlam, Keith T. Muir, Cheryl L. Westmoreland, Peter S. Sebel, John F. Hoke, Carl C. Hug
Publikováno v:
Anesthesia and analgesia. 80(5)
Remifentanil is a new potent opioid analgesic that undergoes rapid esterase metabolism. The purpose of this study was to investigate hemodynamic responses to 2-30 micrograms/kg remifentanil (escalating doses) injected as a bolus over 1 min during gen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3014dd9636b2a1ce19fd81ed05b0c0ed
https://pubmed.ncbi.nlm.nih.gov/7726445
https://pubmed.ncbi.nlm.nih.gov/7726445
Autor:
Neil M. Sussman, Kelly K. Antony, John F. Hoke, Lianng Yuh, James M. Elberfeld, Richard A. Okerholm
Publikováno v:
Journal of clinical pharmacology. 33(5)
The pharmacokinetics of vigabatrin were investigated after single and multiple oral doses in two groups of 24 healthy male volunteers. Vigabatrin was well tolerated by the volunteers; headache was the most frequently reported adverse event. There wer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1c08d4bdd42dddede68db60aee743b2
https://pubmed.ncbi.nlm.nih.gov/8331204
https://pubmed.ncbi.nlm.nih.gov/8331204
Autor:
William R. Ravis, John F. Hoke
Publikováno v:
Journal of pharmaceutical sciences. 81(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b0a5af05d4cc1ea84fcf8e0ed7cf7f5
https://pubmed.ncbi.nlm.nih.gov/1501081
https://pubmed.ncbi.nlm.nih.gov/1501081
Autor:
David J. Hermann, Charles F. Minto, Talmage D. Egan, Steven L. Shafer, Valerie Billard, John F. Hoke, Katherine H. P. Moore, George F. Rich, Harryj M. Lemmens, Pedro L. Gambús, Keith T. Muir, Jaap W. Mandema, Thomas W. Schnider, Elizabeth J. Youngs
Publikováno v:
Survey of Anesthesiology. 41:337
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::797dd30bcf8ee5c5b84964b45dcc0365
https://doi.org/10.1097/00132586-199712000-00024
https://doi.org/10.1097/00132586-199712000-00024
Publikováno v:
Survey of Anesthesiology. 40:32
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::028042aa9f6d0123decd96564774129d
https://doi.org/10.1097/00132586-199602000-00033
https://doi.org/10.1097/00132586-199602000-00033
Autor:
John F. Hoke, William R. Ravis
Publikováno v:
MRS Proceedings. 110
The effect of a perfluorochemical blood substitute (Fluosol-DA 20%) on the disposition kinetics of digoxin in the dog was studied. An intravenous dose of digoxin was administered at either 0.25 or 24 hours following a 30% blood exchange with the dog'
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d7120bacbb94787f138f7052376116e
https://doi.org/10.1557/proc-110-141
https://doi.org/10.1557/proc-110-141